The secretion of IL-1α by the cancer cells enhances the metastatic potential, immune evasion capabilities, and proliferation rate in pancreatic cancer (Matsuo et al., 2004; Matsuo et al., 2009; Melisi et al., 2009; Xu et al., 2010). The gene discussed is IL1A; the disease is familial pancreatic carcinoma.